ImmunityBio
IBRX
#3374
Rank
C$4.77 B
Marketcap
$6.85
Share price
0.83%
Change (1 day)
37.70%
Change (1 year)

ImmunityBio (IBRX) - Cash on Hand

Cash on Hand as of June 2024 : C$0.30 Billion

According to ImmunityBio's latest financial reports the company has C$0.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ImmunityBio - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$0.14 B-64.01%
2021-12-31C$0.40 B229.96%
2020-12-31C$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.40 B 31.39%๐Ÿ‡บ๐Ÿ‡ธ USA